Dr. Michael P. Kosty, MD

Dr. Kosty practices in La Jolla, California.

Dr. Kosty's NPI, 1801857099, was assigned on March 29, 2006. Dr. Kosty graduated from George Washington University School of Medicine in 1979. Dr. Kosty holds California license G43511.

Dr. Kosty's practice address in the NPI Registry is 9888 Genesee Ave, La Jolla, CA 92037, in San Diego County. The practice phone is (858) 554-9559.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kosty practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kosty's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kosty is board certified in hematology by the American Board of Internal Medicine. Dr. Kosty is licensed in California.

Dmand AI lists breast cancer, chronic anemia, lung cancer and prostate cancer among the conditions Dr. Kosty treats.

CMS data shows 5,172 Medicare services from Dr. Kosty across 10 procedure codes in 2024, for 225 Medicare patients. Medicare paid $234,545 for them. Every service was in an office.

CMS counts 225 Medicare patients who saw Dr. Kosty in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kosty's median patient age at 77, with 26% women.

In 2024, Dr. Kosty wrote 714 Medicare Part D claims for 159 patients. 89% of them were for generic drugs. CMS names the drug for 505 of them, across 14 drugs with 11 or more claims each, at $407,386 in total drug cost. In 2023, CMS named 2,024 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kosty for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 47 papers to Dr. Kosty, published from 2005 to 2022. 2015 was the busiest year, with 7. The most frequent topics are Medical Oncology, Societies, Medical and Antineoplastic Combined Chemotherapy Protocols. Dr. Kosty has published most often in J Oncol Pract. Dr. Kosty's most frequent co-authors are Dean F. Bajorin, MD, Michael A. Goldstein, MD and Helen Kent Chew, MD.

Dmand AI links Dr. Kosty to 3 clinical trials. Conditions studied include Carcinoma, Non-Small-Cell Lung, Melanoma and Pancreatic Neoplasms.

CMS Open Payments shows 1,409 general payments to Dr. Kosty from 75 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Bristol-Myers Squibb Company paid the most, $53,985.

Dmand AI lists 2 awards for Dr. Kosty.

Dr. Kosty graduated from George Washington University School of Medicine in 1979. Dr. Kosty is a member of ASCO.

Dr. Kosty is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.